Crypto.com Coin Us Dollar (CRO/USD)

Our currency converter show that the most popular United States USD. The currency code for US Dollar is USD and the symbol of US Dollar is $. Below you will find the currency conversion rates, Pivot points, Technical Indicators and Moving Averages. And also you will find all the current and previous currency details like (5min, 15min, 30min, 1Hr, 5Hr, 1Day, 1week, 1Month) is chart time frame.

Spread: 0.24 CRO/USD Time: 01:29:10

0.083301


Bid/Ask: 0.083277 / 0.083301 High/Low: 0.083806 / 0.081938 Chg/Chg%: +0.00092 / +1.12%

CRO/USD NEWS

The State of Privacy in Ad Tech By Site Author - 3 weeks ago

As we hit the midpoint of 2025, whats the current state of privacy in ad tech?  As 2025 progresses, the ad industrys tug-of-war between regulation and privacy in practice continues. While some playe… [+3948 chars]...

Read more
Clinical Trial Management System Market Size to Hit USD 5.93 Billion by 2032, Fueled by AI Integration and Rising Clinical Trial Complexity – SNS Insider By SNS - 4 weeks ago

Austin, June 04, 2025 (GLOBE NEWSWIRE) -- Clinical Trial Management System Market Size & Growth Analysis: According to SNS Insider, The Clinical Trial Management System Market size was estimated… [+6513 chars]...

Read more
Pharmaceutical Contract Manufacturing and Research Services Market Report 2025-2030 | Demand for Affordable Generics and Biosimilars Drives Growth in Contract Pharma Services By Research - 1 week ago

Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Contract Manufacturing and Research Services Market Size, Share & Trends Analysis Report by Service (Manufacturing, Research), Region… [+6546 chars]...

Read more
Non-alcoholic Steatohepatitis Biomarkers Market to Hit USD 9.1 Billion by 2032 – SNS Insider By SNS - 3 weeks ago

Austin, June 12, 2025 (GLOBE NEWSWIRE) -- Non-alcoholic Steatohepatitis Biomarkers Market Size & Growth Analysis: According to SNS Insider, the Non-alcoholic Steatohepatitis Biomarkers Market wa… [+8669 chars]...

Read more
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program By RENAISSTHERA - 3 weeks ago

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (RenaissThera), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery pro… [+2716 chars]...

Read more
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program By RENAISSTHERA - 3 weeks ago

BENGALURU, India, June 10, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited (RenaissThera), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery pro… [+2716 chars]...

Read more
Top Crypto
PairPrice Chg
BTC/USD 109830.0 +630
+0.58%
LTC/USD 88.771 +1.327
+1.52%
ETC/USD 17.0000 -0.07
-0.41%
XRP/EUR 1.92615 +0.02542
+1.34%
BTC/EUR 93228.0 +865
+0.94%
BTC/AUD 166689.725 +1154.27
+0.7%
BTC/JPY 15839534 +189299
+1.21%
ETH/JPY 371920 0
0%